BIA Ceuticals

Company Overview

Snapshot

Founded in February 2017 by Guy Landver, Tom Gross, and Eytan Moor, BIA Ceuticals operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing natural remedies.

Business overview

BIA Ceuticals is a Health Tech & Life Sciences company specializing in the development of smart botanical pharmaceutical products. The company focuses on creating natural alternatives to standard treatments for common symptoms, aiming for similar or superior efficacy. Its core technology involves combining proprietary-strain cannabis extracts with other natural active ingredients, formulated into creams and ointments for skin disorders like psoriasis, acne, and hemorrhoids. BIA Ceuticals serves the pharmaceutical and cosmetics markets, operating within the Medical Cannabis, Pharma & Medical Biotechnology, and Herbals sectors.

Company Intelligence Q&A

What is BIA Ceuticals' primary focus?

BIA Ceuticals is focused on developing natural remedies by combining medical cannabis with medicinal plants to create pharmaceutical products for various common symptoms and skin disorders.

What types of products does BIA Ceuticals develop?

BIA Ceuticals develops a series of creams and ointments, including products like Acnecann, Dermacann, Psorcann, and Proctocann, designed for the treatment of common skin disorders such as psoriasis, acne, and hemorrhoids.

What is the key technology behind BIA Ceuticals' products?

The company's products incorporate a novel patented delivery system designed to enhance the absorption and local bioavailability of cannabidiol and other active ingredients.

What preclinical results has BIA Ceuticals achieved?

BIA Ceuticals has completed initial tests on the active compounds of its products in an inflammation model using human skin cells, showing a 65-85% reduction of pro-inflammatory markers and a 45% improvement in skin cell survival.

When was BIA Ceuticals founded?

BIA Ceuticals was founded in February 2017.